“…The 5-year survival was also different based on the Shin scoring system ranging from 94.4 % in score 0–1 group, to 71.8 % in score 4–5 group. The Shin scoring system was later validated in a European cohort involving 11 countries and 567 patients overall: sensitivity and specificities for predicting malignancy were respectively 57.3 % and 64.4 % for a Shin score of 3, 21.7 % and 90.4 % for a Shin score of 4 %, and 4.2 % and 98.6 % for a Shin score of 5 [33] . Authors conclude that a Shin score of 1 or less should be monitored, while those with scores of 4 or more should undergo surgery [33] .…”